AIIMS signs MoU with Wipro GE Healthcare to set up AI health innovation hub

Published On 2024-12-14 11:15 GMT   |   Update On 2024-12-14 11:16 GMT

New Delhi: All India Institute of Medical Sciences (AIIMS), New Delhi signed a Memorandum of Understanding (MoU) with Wipro GE Healthcare Pvt Ltd, a leading global provider of healthcare technologies, to establish an AI Health Innovations Hub. 

The new hub will focus on the development of products and solutions that enhance healthcare delivery and outcomes through more precise diagnosis, innovative treatment protocols, and real-time patient data tracking.

As the technology partner, Wipro GE Healthcare will invest around $1 million over the next five years to co-develop, test, & deploy intelligent systems and workflow solutions in cardiology, oncology, and neurology. As clinical partner for the hub, AIIMS will provide multi-modal clinical inputs, and function as a real-world clinical environment for evaluation, feedback, and deployment of GE HealthCare’s AI-enabled solutions. A joint working committee from both organizations will oversee the collaboration, which will include clinical research and academic engagement.

Also Read:Dont like the food? Now give feedback to AIIMS on inpatient diet

According to The National AI Portal of India (INDIAai), AI technology promises a transformative leap for India's healthcare system by 2025, potentially boosting the GDP by $25-30[1]. Connecting longitudinal data (i.e. imaging, lab results, medical records, etc.) and layering it with analytics and AI can significantly enhance diagnosis, streamline operations, and improve patient care nationwide.

Dr M Srinivas, Director, AIIMS, New Delhi said, “This partnership with Wipro GE Healthcare holds strategic value and is aligned with the national vision of Viksit Bharat through advanced healthcare. As an institution, AIIMS has been committed to advancing healthcare through clinical research and practical applications to improve patient care. With its forward vision of precision care and proven expertise in the field of AI, Wipro GE Healthcare compliments our vision. We are optimistic that with this collaboration we will be able to accelerate the development and validation of advance MedTech and offer more effective care for patients.”

Parminder Bhatia, Chief AI Officer, GE HealthCare said, "The Indian healthcare industry has experienced rapid growth, driven by supportive government policies, innovative domestic solutions, and the integration of digital technologies and AI.

We view AI not merely as a tool but as a transformative force to democratize healthcare and enable increased predictiveness, prevention, and precision. Our collaboration with AIIMS to establish the ‘AI Health Innovations Hub’ represents a significant advancement in this journey. We are excited to embark on this path and work towards accelerating the development and validation of cutting-edge healthcare solutions and enhance patient outcomes."

Chaitanya Sarawate, Managing Director, Wipro GE Healthcare South Asia added, “Wipro GE Healthcare has a proud legacy of innovation in MedTech. The future of healthcare in India will be driven by technology with AI at the heart of innovation to enable predictive, personalized and preventive care at scale.

With its transformative vision, diverse patient pool and scale, AIIMS has been at the forefront of redefining care. This collaboration is a strong step forward in developing foundation models for transformative clinical care and applications for India and the world.”

Also Read:Garbage Spills Near AIIMS: Delhi Pollution Control Committee Raises Concern

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News